Nivolumab discontinuation and retreatment in patients with relapsed or refractory Hodgkin lymphoma
Liudmila Fedorova, Kirill V. Lepik, N. Mikhailova, Elena Kondakova, Yuri R. Zalyalov, Vadim Baykov, Elena V. Babenko, Andrey V. Kozlov, Ivan Moiseev, Boris V. Afanasyev
Topics & Concepts
NivolumabMedicineDiscontinuationRefractory (planetary science)Internal medicineRetrospective cohort studyHematologyLymphomaAdverse effectOncologySurgeryGastroenterologyImmunotherapyCancerAstrobiologyPhysicsLymphoma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersGastrointestinal Tumor Research and Treatment